CAV1 inhibition in MM cells did not affect their sensitivity to bortezomib in the presence of glutamine, while it significantly increased the sensitivity to bortezomib in the absence of glutamine (Figure 6M; Figure S8F, Supporting Information). Here, CAV1 is linked to Miyoshi myopathy.